Colorado Blood Cancer Institute at Presbyterian St. Luke's — Denver, Colorado

Colorado Blood Cancer Institute at Presbyterian St. Luke's is a clinical research site located in Denver, Colorado, United States 80218.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Colorado Blood Cancer Institute at Presbyterian St. Luke's has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia.

Sponsors: Center for International Blood and Marrow Transplant Research.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Colorado Blood Cancer Institute at Presbyterian St. Luke's?

Colorado Blood Cancer Institute at Presbyterian St. Luke's has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Colorado Blood Cancer Institute at Presbyterian St. Luke's conducted?

Colorado Blood Cancer Institute at Presbyterian St. Luke's has 1 clinical trials on record, with 1 currently active. Their work covers Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia.

Is Colorado Blood Cancer Institute at Presbyterian St. Luke's accredited by Crixeo Health?

Colorado Blood Cancer Institute at Presbyterian St. Luke's has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Colorado Blood Cancer Institute at Presbyterian St. Luke's?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.